Indigo therapeutics has been selected for the MedStartUp Days organized by Business France and The Galien Foundation in New York City next October 27th.
Indigo designs, manufactures and supplies innovative dietary supplements focused on gastrointestinal tract pathologies and conditions or deficiencies requiring specific clinical nutrition.
‘specialized’ dietary supplements on the basis of a strong and validated medico-scientific rational
products with the same level of requirement for drugs (GMP-like)
exclusive distribution licenses by countries with pharmaceutical companies with a specific sales force
prescription of the products by the medical professions
Our R&D aims at producing new generation probiotics / synbiotics combining a selection of relevant strains in relation to the progresses on microbiota, a microencapsulation technology promoting the survival and the production of molecules of interest, and a pharmaceutical macro-encapsulation vectorizing active ingredients to relevant therapeutic targets.
20 years of experience in scientific medical consulting
Former CEO of Draft Healthcare & Proteines communication agencies
30 years of experience in scientific medical consulting
Member of Seventure (private equity fund) advisory board
Scientific director of Enterome & MaaT Pharma
23 years of experience in pharmaceutical industries
Former BD manager of Chemo
10 years of experience in pharmaceutical industries
Former Head of Phytea R&D
Address: 5 rue Salneuve, 75017 Paris, France